Canada Backs Aspect Biosystems With $280M to Scale Bioprinted Tissue Therapies3DPrint.com | Additive Manufacturing Business
The Government of Canada is supporting bioprinting company Aspect Biosystems with a new $280 million project to help develop and manufacture its bioengineered cellular medicines. The project will run over multiple years and is intended to move the company’s therapies closer to clinical use while expanding its production capabilities in Canada. The partnership was announced […]




